Metraipolis › archive › dc_5f256da4cbdd

Molecular docking analysis with IC50 Assay FAK against for FDA approved drugs — Europe PMC PMID:41466656

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41466656
DOI
10.6026/973206300213165
License (as archived)
solo-consultazione
Archived
2026-11-09T16:50:47.239Z
SHA-256 of the archived text
0505a2c05e1cd385ba7e4aafb6d27cf21a4bd5d6f8202ce06448ad23aa819a5a
Stable URL of this page
https://metraipolis.com/documento/dc_5f256da4cbdd

How to cite

Molecular docking analysis with IC50 Assay FAK against for FDA approved drugs — Europe PMC PMID:41466656 — Europe PMC (en), https://europepmc.org/article/MED/41466656 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_5f256da4cbdd (Metraipolis archive dc_5f256da4cbdd, sha256 0505a2c05e1cd385ba7e4aafb6d27cf21a4bd5d6f8202ce06448ad23aa819a5a)
BibTeX
@misc{dc5f256da4cbdd,
  title = {Molecular docking analysis with IC50 Assay FAK against for FDA approved drugs — Europe PMC PMID:41466656},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41466656},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_5f256da4cbdd; sha256 0505a2c05e1cd385ba7e4aafb6d27cf21a4bd5d6f8202ce06448ad23aa819a5a},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41466656. Agents can read the archived copy with the MCP tool read_document.